Everything below concerns half-life. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-06-27. Numbers and descriptions here follow the published literature rather than marketing material.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.
The semaglutide sequence is a 31-residue analogue of human GLP-1, altered at three positions relative to the parent hormone. Aminoisobutyric acid replaces alanine at position 8, arginine replaces lysine at position 34, and a lipophilic diacid is attached to lysine 26 through a short linker. These features are reported consistently in the structural literature. The position 8 substitution blocks recognition by dipeptidyl peptidase-4, while the attached chain drives strong, reversible association with a carrier protein in blood.
Receptor activation raises intracellular cyclic AMP through Gs coupling, which promotes glucose-dependent insulin release and suppresses glucagon secretion when blood glucose is elevated. Effects outside the pancreas include slower gastric emptying and altered appetite signalling in the hypothalamus and hindbrain. The relative contribution of each tissue to overall metabolic outcomes remains an area of active investigation. Central mechanisms in particular are inferred mainly from animal models and indirect human measures rather than direct observation.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | Peptide backbone with a C18 fatty diacid side chain |
| Molecular weight | Approximately 4113 Da | Consistent with a 31-residue peptide plus linker |
| Appearance | White to off-white powder | Lyophilized solid; hygroscopic if left open |
| Solubility class | Sparingly soluble to soluble in water | Varies with pH and ionic strength |
| Typical analytical method | Reversed-phase HPLC with UV detection | Often paired with mass spectrometry for identity |
As a peptide, semaglutide is sensitive to conditions that break amide bonds or modify side chains. Deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation are the main degradation routes described in published stability work. Rate depends strongly on pH, buffer species, ionic strength, temperature and exposure to light. Formulators therefore choose a defined solution pH and often add excipients such as phosphate buffer, propylene glycol and phenol, each of which plays a separate role in pH control, tonicity or preservation.
Storage guidance for the finished injectable product distinguishes the unused state from the in-use state. Before first use, pens are kept refrigerated between 2 and 8 degrees Celsius, protected from light, and never frozen, since freezing can disrupt the peptide or the device. After first use, label instructions in several markets permit storage at room temperature up to about 30 degrees Celsius for a limited number of days. Solid research-grade material is normally held at or below minus 20 degrees Celsius, often with desiccant, and allowed to equilibrate before opening.
Reported molecular weight is approximately 4113.6 daltons for the free base, and the peptide is supplied as a lyophilized powder or in buffered liquid form depending on the intended use. It is freely soluble in water when formulated with appropriate excipients, though the unconjugated peptide shows limited stability at neutral pH over long periods. Analytical characterization typically relies on reversed-phase high-performance liquid chromatography and mass spectrometry. Purity specifications for research-grade material commonly exceed ninety-five percent by area. Isotopic and impurity profiles differ between suppliers.
Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.
The Revolution of 1905–1907 in Russian Poland, the result of many years of pent-up political frustrations and stifled national ambitions, was marked by political maneuvering, strikes and rebellion. The revolt was part of much broader disturbances throughout the Russian Empire associated with the general Revolution of 1905. In Poland, the principal revolutionary figures were Roman Dmowski and Józef Piłsudski. Dmowski was associated with the right-wing nationalist movement National Democracy, whereas Piłsudski was associated with the Polish Socialist Party. As the authorities re-established control within the Russian Empire, the revolt in Congress Poland, placed under martial law, withered as well, partially as a result of tsarist concessions in the areas of national and workers' rights, including Polish representation in the newly created Russian Duma. The collapse of the revolt in the Russian Partition, coupled with intensified Germanization in the Prussian Partition, left Austrian Galicia as the territory where Polish patriotic action was most likely to flourish. In the Austrian Partition, Polish culture was openly cultivated, and in the Prussian Partition, there were high levels of education and living standards, but the Russian Partition remained of primary importance for the Polish nation and its aspirations. About 15.5 million Polish-speakers lived in the territories most densely populated by Poles: the western part of the Russian Partition, the Prussian Partition and the western Austrian Partition.
== Cultivation == Some varieties and hybrids have been in Western cultivation for the last 100 to 150 years. There is now a wide array of new Chinese species being cultivated in the West, many of which have only recently been discovered, and some of which have yet to be named. There are also many older Japanese hybrids and forms, extending the boundaries of the genus in cultivation. The majority of the Chinese species have not been fully tested for hardiness nor indeed for any other aspect of their culture. The initial assumption that the plants would only thrive where their native conditions could be closely replicated have proven to be overly cautious, as most varieties are proving extraordinarily amenable to general garden and container cultivation. The cultivar 'Amber Queen' is a recipient of the Royal Horticultural Society's Award of Garden Merit.
==== Schizophrenia ==== Modafinil and armodafinil were studied as a complement to antipsychotic medications in the treatment of schizophrenia. They showed no effect on positive symptoms or cognitive performance. A 2015 meta-analysis found that modafinil and armodafinil may slightly reduce negative symptoms in people with acute schizophrenia, though they do not appear useful for people with stable schizophrenia who have prominent negative symptoms (such as reduced motivation or social withdrawal). Among medications demonstrated to be effective for reducing negative symptoms in combination with antipsychotics, modafinil, and armodafinil are among the smallest effect sizes.
Sources: en.wikipedia.org
=== Halogenation === Direct difluoromethylation via Zn(SO2CF2H)2 N–X Anomeric Amides as Electrophilic Halogenation Reagents (2023) Guanidine-based chlorinating reagent, CBMG or "Palau'chlor" (2014) Regioselective bromination of N-oxides (2013)
=== Pregnancy and lactation === Experimental animal studies did not indicate injurious effects of opipramol on the embryonic development or fertility. Opipramol should only be prescribed during pregnancy, particularly in the first trimester, for compelling indication. It should not be used during lactation and breastfeeding, since it passes into breast milk in small quantities.
=== July === 1 July – Reform UK accuses the chief executive of Warwickshire County Council of staging a "coup d'état" after she refused to remove a Progress Pride flag from the county's Shire Hall before the end of Pride Month. 2 July – A report by the Senedd Standards Commission finds that First Minister of Wales Eluned Morgan failed to declare a donation from the Unite union. 3 July – Zarah Sultana, suspended from the Parliamentary Labour Party in 2024, announces she is leaving Labour to establish a political party with former Labour leader Jeremy Corbyn. 4 July – Linden Kemkaran, Reform UK's leader of Kent County Council, attracts criticism over a social media post in which he said transgender-related books would be removed from the county's libraries with immediate effect, and described the decision as a "victory for common sense in Kent". 5 July – Foreign Secretary David Lammy becomes the first UK minister to visit Syria since the outbreak of the Syrian Civil War in 2011, and meets interim president Ahmed al-Sharaa. The UK government also announces £94.5m of financial support to help the country's recovery. James McMurdock, elected as the Reform UK MP for South Basildon and East Thurrock at the last election, relinquishes the party whip after The Sunday Times raised questions about business loans he took out during the COVID-19 pandemic.
Sources: en.wikipedia.org
It is given either as a once-weekly subcutaneous injection or as an oral tablet taken once daily. The two forms use different absorption strategies, so they are not interchangeable on a milligram-for-milligram basis.
Structural modifications, including a fatty acid side chain and non-natural amino acid substitutions, slow enzymatic breakdown and promote albumin binding. These changes support once-weekly dosing rather than twice-daily administration.
The pathways involving insulin, glucagon, gastric emptying, and appetite signaling are well described. How much each pathway contributes to weight reduction in a given person is not fully established.
It is a synthetic peptide of 31 amino acids, built to resemble the natural incretin hormone GLP-1. Because of its size and composition it is handled analytically like other therapeutic peptides, using chromatographic and mass spectrometric methods rather than the techniques typical of small organic drugs.